Schizoaffective Disorders Completed Phase 4 Trials for Agomelatine (DB06594)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01822418Agomelatine Treatment of Depression in Schizophrenia (AGOPSYCH)Treatment